Yuri Weigel practices corporate law, with a focus on representing emerging and public companies, including venture capital financings, public offerings and mergers and acquisitions.

Download full bio 


  • Rodeo Therapeutics Agrees to Sell to Amgen for $721 Million 

  • ConvergeOne Announces $1.2 Billion Combination With Forum Merger to Become Public Company 

  • Alder Biopharmaceuticals $80 Million Initial Public Offering 


  • George Washington University Law School
    JD, With highest honors, Order of the Coif, 2013

  • University of Washington
    BA, Comparative History of Ideas
    magna cum laude, 2007

Admissions & Credentials